Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
In November 2023, CDC published new recommendations for hepatitis C testing for perinatally exposed infants and children.News Article updated on 12/19/2023
-
Huntridge Rapid Start Initiative
The Huntridge Family Clinic launched the Rapid Start Initiative to provide same-day ART treatment and comprehensive case management to clients with a new diagnosis of HIV. Over 90% of clients received ART on the same day as diagnosis, and 78% of clients were retained in care within the first year of starting treatment.Resource from the RWHAP Best Practices Compilation updated on 01/08/2024
-
Positive Care Center Rapid Access
Positive Care Center implemented the Rapid Access program in 2018, providing clients with ART on the same day as HIV diagnosis. Pharmacists, embedded within Positive Care Center’s care team, help clients with their treatment plans and adherence strategies. Over 90% of clients served through Rapid Access in 2021 received ART on the same day as diagnosis, and 82% of clients were retained in care at six months.Resource from the RWHAP Best Practices Compilation updated on 01/12/2024
-
Kern County Rapid ART
Kern County Rapid ART links people with a new diagnosis of HIV to ART. The Kern County Health Officer’s Clinic identifies people with a new diagnosis of HIV through onsite testing, surveillance data, and referrals from local hospital emergency departments. Kern County Rapid ART provides support services and refers clients to other community clinics for ongoing care. A study of clients with a new diagnosis of HIV in 2021 found that on average, Kern County Rapid ART clients were linked to care and provided ART within two days of diagnosis.Resource from the RWHAP Best Practices Compilation updated on 01/24/2024
-
Tech/Mobile Apps Supporting HIV Care
Technology-focused tools to support HIV care engagement.Blog updated 04/10/2023
-
NIH Center Efforts Towards the EHE Initiative: Innovative Partnerships to Implement New Tools
Implementation of innovations for End the HIV Epidemic (EHE) efforts requires innovative research/community collaborations. This session presents LA County’s efforts to prepare for long-acting injectable treatment, Miami’s pilot of telemedicine for test-and-treat at a syringe services program, and Philadelphia’s partnership to evaluate a U=U campaign.
Resource (Conference Presentation) updated 09/14/2023
-
Updates from Recent HIV Research Conferences: CROI 2020 and AIDS 2020
Review of research insights from two major HIV conferences held in 2020.Resource (Conference Presentation) updated 09/14/2023
-
New and Investigational ART Drugs and Strategies
Review of antiretroviral regimens in the clinical trials phase.Resource (Conference Presentation) updated 09/14/2023
-
Treating HIV in 2020: Interactive Cases From the Clinic(ians) and Panel Discussion
Case examples of starting antiretroviral therapy in patients under varied scenarios.Resource (Conference Presentation) updated 09/14/2023
-
Integrating Buprenorphine Therapy Into HIV Primary Care Settings
This report highlights projects found to offer highly effective (and replicable) approaches to integrating buprenorphine-based medication-assisted treatment into HIV/AIDS primary care. Chapters outline the processes programs need to put in place, including meeting DATA 2000 regulatory requirements, achieving institutional buy-in, implementing staff training requirements, and evaluating processes and outcomes.
Resource updated 04/02/2024
-
Rapid ART Dissemination Assistance Provider
Project to facilitate the implementation of Rapid ART initiation in RWHAP provider settings by compiling and disseminating implementation resources nationwide. Project period: 2020-2023.RWHAP Technical Assistance Provider updated on 03/04/2024
-
Four Evidence-Information HIV Care Interventions
Four evidence-informed interventions from the DEII initiative on peers, patient navigation, buprenorphine treatment, and care coordination.Blog updated 09/06/2022
-
I Am a Long-term Survivor of HIV
To prepare for this blog, I keep asking myself: What does it mean to be a “long-term survivor” of HIV?Blog updated 06/08/2022
-
Organizational HIV Treatment Cascades Used to Improve Statewide Quality of Care Results
Resource (Conference Presentation) updated 09/14/2023
-
Eligibility for Simplification of HIV Salvage Regimens Based on Genotypic
Resource (Conference Presentation) updated 09/14/2023
-
Adolescent Viral Load Suppression: Challenges and Success Stories
Resource (Conference Presentation) updated 09/14/2023
-
Average Time to Initiation of Antiretroviral Therapy - Newly Diagnosed HIV Patients - University of Utah
Resource (Conference Presentation) updated 09/14/2023
-
Rapid Access of Initial HIV Appointment and ART Prescription
Resource (Conference Presentation) updated 09/14/2023
-
New Investigational ART Drugs and Strategies
Review of investigational drugs in phase III trials (as of 2021: Islatravir, Lenacapravir, GSK 3640254/aka GSK “254) and how these investigational agents might be used in treatment in the future. Also, review of long-acting injectables.Resource (Conference Presentation) updated 09/14/2023
-
Managing Polypharmacy and Drug-Drug Interactions
Review of common mechanisms for drug interactions with contemporary ART; therapeutic classes of drugs with high interaction potential with ART; distinctions between oral vs intramuscular cabotegravir/rilpivirin interactions; and comparison of the clinical pharmacology and drug interaction potential of tenofovir alafenamide vs tenofovir disoproxilfumarate.Resource (Conference Presentation) updated 09/14/2023